伊士曼化工 2024年度报告

(MarkOne)☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year endedDecember 31, 2024OR☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from ______________ to ______________ Commission file number1-12626 EASTMAN CHEMICAL COMPANY(Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization)(I.R.S. employer identification no.) Registrant's telephone number, including area code:(423)229-2000 Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of theSecurities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant wasrequired to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or forsuch shorter period that the registrant was required to submit such files). Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, asmaller reporting company, or an emerging growth company.See the definitions of "large accelerated filer,""accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.Large accelerated filer☒Accelerated filer☐ Smaller reporting companyEmerging growth company Non-accelerated filer☐☐☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transitionperiod for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) ofthe Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment ofthe effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financialstatements of the registrant included in the filing reflect the correction of an error to previously issued financialstatements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis ofincentive-based compensation received by any of the registrant’s executive officers during the relevant recoveryperiod pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). The aggregate market value (based upon the $97.97 closing price on the New York Stock Exchange on June 28, 2024) of the114,432,187 shares of common equity held by non-affiliates as of December31, 2024 was $11,210,921,360using beneficialownership rules adopted pursuant to Section 13 of the Securities Exchange Act of 1934 to exclude common stock that may be deemedbeneficially owned as of December31, 2024 by Eastman Chemical Company's directors and executive officers and charitablefoundation, some of whom might not be held to be affiliates upon judicial determination. A total of115,168,382shares of commonstock of the registrant were outstanding at December31, 2024. DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant's definitive Proxy Statement for the 2025 Annual Meeting of Stockholders, to be filed with the Securities andExchange Commission, are incorporated by reference in Part III, Items 10 to 14 of this Annual Report on Form 10-K (this "AnnualReport") as indicated herein. Certain statements made or incorporated by reference in this Annual Report are "forward-looking statements" within the meaning ofthe Private Securities Litigation Reform Act (Section 27A of the Securities Act of 1933, as amended, and Section 21E of the SecuritiesExchange Act of 1934, as amended). Forward-looking statements are all statements, other than statements of historical fact, that maybe made by Eastman Chemical Company ("Eastman" or the "Company") from time to time. In some cases, you can identify forward-looking statements by terminology such as "anticipates", "believes", "estimates", "expects", "intends", "may", "plans", "projects","forecasts", "will", "would", "could", and similar expressions, or expressions of the negative of these terms. Forward-lookingstatements may relate to, among other things, such matters as planned and expected capacity increases